National Healthcare Properties, Inc. 7.125% Series B Cumulative Redeemable Perpetual Preferred Stock financials
$25.42+0.04%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 |
|---|---|---|
| Revenue | $87.5M | $86.3M |
| Gross profit | $87.5M | $86.3M |
| Gross margin | 100.0% | 100.0% |
| Operating income | $5.1M | $10.1M |
| Net income | -$8.1M | -$7.6M |
| Net margin | −9.3% | −8.8% |
| Diluted EPS | $-0.13 | $-0.27 |
| EBITDA | $27.0M | $27.8M |
| Operating cash flow | $21.6M | $9.0M |
| Free cash flow | $16.3M | $3.7M |
| Diluted shares | 61.6M | 28.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 |
|---|---|---|
| Cash & equivalents | $245.7M | $52.8M |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $848.2M | $1.04B |
| Total assets | $1.98B | $1.70B |
| Total liabilities | $919.0M | $1.10B |
| Shareholders' equity | $1.06B | $596.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology